Related Experiment Video
Updated: Aug 15, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
[Expert consensus on treatment of severe COVID-19 caused by Omicron variants]
Insights
Severe novel coronavirus (COVID-19) Omicron variant infections present critical care challenges in China. This recommendation standardizes management to minimize mortality for critically ill patients.
Area of Science:
- Pulmonary and Critical Care Medicine
- Infectious Diseases
- Epidemiology
Context:
- Recent surge of severe COVID-19 cases caused by Omicron variants in China.
- Critical care units face significant challenges in managing these severe infections.
- Need for standardized protocols among healthcare professionals with diverse backgrounds.
Purpose:
- To provide a standardized procedural recommendation for managing critically ill COVID-19 patients.
- To address the challenges faced by medical institutions in China.
- To minimize mortality rates associated with severe Omicron variant infections.
Summary:
- Developed by pulmonary and critical care experts from the Chinese Thoracic Society and Chinese Association of Chest Physicians Critical Care Group.
- Based on current medical evidence and clinical practice.
- Aims to standardize the clinical treatment of patients with severe novel coronavirus infection.
Impact:
- Facilitate consistent and effective critical care for severe COVID-19 patients.
- Improve patient outcomes and reduce mortality.
- Serve as a guideline for healthcare providers across China facing this public health crisis.
Abstract:
Severe novel coronavirus infection (COVID-19) caused by Omicron variants has arisen in many places of China recently, and critical care is currently the biggest challenge for medical institutions in China. How to manage these patients in a procedural and standardized way to minimize the mortality is a problem that the medical staff with different professional backgrounds has to face. Therefore, the Chinese Thoracic Society and Chinese Association of Chest Physicians Critical Care Group jointly initiated and organized pulmonary and critical care experts to write this recommendation based on the current medical evidence and clinical practice, in order to standardize the clinical treatment of critically ill patients.
More Related Videos
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Endocarditis III: Medical Management
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: